Onward Medical N.V. (EBR:ONWD)
2.830
+0.025 (0.89%)
May 22, 2026, 5:35 PM CET
Onward Medical Company Description
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally.
The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities.
Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.
| Country | Netherlands |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 137 |
| CEO | David Marver |
Contact Details
Address: Schimmelt 2 Eindhoven, NL-5611 Netherlands | |
| Website | onwd.com |
Stock Details
| Ticker Symbol | ONWD |
| Exchange | Euronext Brussels |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | NL0015000HT4 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David L. Marver | Chief Executive Officer and Executive Director |
| Dr. Gregoire Courtine Ph.D. | Co-Founder and Senior Advisor |
| Ali Kiboro | Chief Financial Officer |
| Robert W. Odell | Vice President of Operations |
| Lorenzo Fanti | Vice President of Legal |
| Sebastien Cros | Vice President of Communications |
| Alexandre Casteau | Head of Strategy and Corporate Development |
| Julie Crom | Director of People and Culture |
| Sean Sciara | Chief Commercial Officer |
| Shari O'Quinn | Chief Clinical, Regulatory and Quality Officer |